Patel Amol, Gupta Vineet Govinda, Guleria Bhupesh, Das Chandan K, Mehta Prashant, Ramegowda Kaushik Mahadevapura
Department of Medicine, Oncology Centre, Indian Naval Hospital Ship, Asvini, Colaba, Mumbai, Maharashtra, India.
Department of Medical Oncology, Artemis Hospitals, Gurgaon, Haryana, India.
South Asian J Cancer. 2022 Feb 5;11(1):9-13. doi: 10.1055/s-0041-1739187. eCollection 2022 Jan.
Amol Patel In India, breast cancer patients' post-treatment follow-up practices are not known. We did this survey to understand how the breast cancer patients are followed-up and tried to explore the challenges associated with it. We conducted a survey-based study among Indian oncologists. Seven questions were framed pertaining to follow-up practices. Answers were provided in the form of multiple options. Google forms platform was used. Survey was circulated through social media apps and through mail. We sought suggestions and opinions to address the challenges from participants. A total of 158 medical oncologists responded to this survey. 10% were not aware that only history and clinical examination are the scientific recommendations for follow-up. Ninety percent of the medical oncologists felt clinical breast examination as an uncomfortable practice for patients and physicians and 39% ordered a chest X-ray and an ultrasound abdomen. Annual mammogram was ordered by 83%, and blood investigations were recommended by 14% routinely. The majority (49.6%) felt that the absence of a female attendant, physician and patient factors were responsible for nonadherence to clinical breast examination. The DEXA scan was recommended by 84 (53%) medical oncologists regularly for patients on aromatase inhibitors, while 23 (14%) did not recommend it. There is a disparity between scientific recommendations and real-world follow-up practices. A large number of medical oncologists relied on chest X-ray and ultrasound abdomen. There is an unmet need to address this issue.
阿莫尔·帕特尔 在印度,乳腺癌患者治疗后的随访情况尚不清楚。我们开展这项调查是为了了解乳腺癌患者是如何接受随访的,并试图探究与之相关的挑战。
我们对印度肿瘤学家进行了一项基于调查的研究。针对随访情况设计了七个问题。答案以多项选择的形式提供。使用了谷歌表单平台。通过社交媒体应用程序和邮件发放调查问卷。我们向参与者征求应对挑战的建议和意见。
共有158名医学肿瘤学家回复了此项调查。10%的人不知道仅病史和临床检查是随访的科学建议。90%的医学肿瘤学家认为临床乳腺检查对患者和医生来说都是一种不舒服的做法,39%的人会安排胸部X光和腹部超声检查。83%的人会安排年度乳房X光检查,14%的人常规建议进行血液检查。大多数人(49.6%)认为缺乏女性陪同人员、医生和患者因素是不坚持进行临床乳腺检查的原因。84名(53%)医学肿瘤学家经常为使用芳香化酶抑制剂的患者推荐骨密度扫描,而23名(14%)则不推荐。
科学建议与实际随访做法之间存在差异。大量医学肿瘤学家依赖胸部X光和腹部超声检查。解决这个问题存在未满足的需求。